Skip to main content
Top
Published in: BMC Pediatrics 1/2020

01-12-2020 | Sudden Cardiac Death | Case report

Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report

Authors: Stefan Kurath-Koller, Hannes Sallmon, Daniel Scherr, Egbert Bisping, Ante Burmas, Igor Knez, Martin Koestenberger

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

There is only limited experience with wearable cardioverter-defibrillators (WCD) in pediatric patients. We report on the successful application of a WCD in an adolescent patient with hypertrophic cardiomyopathy and myocardial bridging.

Case presentation

A 15-year-old girl presented with a history of recurrent syncope, dyspnea, and vertigo with exercise. Diagnostic work-up revealed non-obstructive hypertrophic cardiomyopathy and signs of myocardial ischemia with exercise. Given this high-risk constellation, the patient was scheduled for prophylactic implantation of an implantable cardioverter-defibrillator (ICD). One month after initial presentation and days prior to the planned ICD implantation, the patient collapsed during an episode of sustained ventricular tachycardia (VT) while running. VT was terminated by WCD shock delivery. Following this event, computerized tomography scan revealed myocardial bridging of the left anterior descending coronary artery causing a 90% stenosis in systole. After coronary surgery, life threatening arrhythmias have not recurred, but due to progressive heart failure, the patient underwent successful heart transplantation after 2 years.

Conclusions

The reported case highlights the importance and applicability of WCDs and the potentially malign nature of myocardial bridging in pediatric high-risk patients.
Literature
1.
go back to reference Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37..CrossRef Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37..CrossRef
2.
go back to reference Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.CrossRef Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.CrossRef
3.
go back to reference Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–8.CrossRef Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–8.CrossRef
4.
go back to reference Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the Europe. Eur Heart J. 2015;36:2793–867.CrossRef Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the Europe. Eur Heart J. 2015;36:2793–867.CrossRef
5.
go back to reference Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB. The US experience of the wearable Cardioverter-defibrillator in pediatric patients. Circ Arrhythm Electrophysiol. 2018;11:e006163.CrossRef Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB. The US experience of the wearable Cardioverter-defibrillator in pediatric patients. Circ Arrhythm Electrophysiol. 2018;11:e006163.CrossRef
6.
go back to reference Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17:1601–87.PubMed Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17:1601–87.PubMed
7.
go back to reference Wolf CM. Hypertrophic cardiomyopathy: genetics and clinical perspectives. Cardiovasc Diagn Ther. 2019;9(Suppl 2):S388–415.CrossRef Wolf CM. Hypertrophic cardiomyopathy: genetics and clinical perspectives. Cardiovasc Diagn Ther. 2019;9(Suppl 2):S388–415.CrossRef
8.
go back to reference Piccini JP Sr, Allen LA, Kudenchuk PJ, Page RL, Patel MR, Turakhia MP, American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Wearable Cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association. Circulation. 2016;133:1715–27.CrossRef Piccini JP Sr, Allen LA, Kudenchuk PJ, Page RL, Patel MR, Turakhia MP, American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Wearable Cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association. Circulation. 2016;133:1715–27.CrossRef
9.
go back to reference Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU, et al. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace. 2017;19:335–45.CrossRef Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU, et al. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace. 2017;19:335–45.CrossRef
10.
go back to reference Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–91.CrossRef Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–91.CrossRef
11.
go back to reference Deyell MW, Krahn AD, Goldberger JJ. Sudden cardiac death risk stratification. Circ Res. 2015;116:1907–18.CrossRef Deyell MW, Krahn AD, Goldberger JJ. Sudden cardiac death risk stratification. Circ Res. 2015;116:1907–18.CrossRef
12.
go back to reference Atallah J, Erickson CC, Cecchin F, Dubin AM, Law IH, Cohen MI, et al. Multi-institutional study of implantable defibrillator Lead performance in children and young adults: results of the pediatric Lead extractability and survival evaluation (PLEASE) study. Circulation. 2013;127:2393–402.CrossRef Atallah J, Erickson CC, Cecchin F, Dubin AM, Law IH, Cohen MI, et al. Multi-institutional study of implantable defibrillator Lead performance in children and young adults: results of the pediatric Lead extractability and survival evaluation (PLEASE) study. Circulation. 2013;127:2393–402.CrossRef
13.
go back to reference Czosek RJ, Cassedy AE, Wray J, Wernovsky G, Newburger JW, Mussatto KA, et al. Quality of life in pediatric patients affected by electrophysiologic disease. Heart Rhythm. 2015;12:899–908.CrossRef Czosek RJ, Cassedy AE, Wray J, Wernovsky G, Newburger JW, Mussatto KA, et al. Quality of life in pediatric patients affected by electrophysiologic disease. Heart Rhythm. 2015;12:899–908.CrossRef
14.
go back to reference Kiess A, Vollroth M, Bakhtiary F, Seki H, Kostelka M, Djukic M, et al. Symptomatic myocardial bridging: a frequently occurring coronary variation can cause severe myocardial ischaemia in affected children with underlying cardiac conditions. Cardiol Young. 2018;28:826–31.CrossRef Kiess A, Vollroth M, Bakhtiary F, Seki H, Kostelka M, Djukic M, et al. Symptomatic myocardial bridging: a frequently occurring coronary variation can cause severe myocardial ischaemia in affected children with underlying cardiac conditions. Cardiol Young. 2018;28:826–31.CrossRef
Metadata
Title
Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report
Authors
Stefan Kurath-Koller
Hannes Sallmon
Daniel Scherr
Egbert Bisping
Ante Burmas
Igor Knez
Martin Koestenberger
Publication date
01-12-2020

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue